title: Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients.
abstract: Phosphatidylserine (PS) is usually confined to the inner leaflet of the red blood cell (RBC) membrane. It may become externalised in various conditions, however, notably in RBCs from patients with sickle cell disease (SCD) where exposed PS may contribute to anaemic and ischaemic complications. PS externalisation requires both inhibition of the aminophospholipid translocase (or flippase) and activation of the scramblase. Both may follow from elevation of intracellular Ca(2+). Flippase inhibition occurs at low [Ca(2+)](i), about 1μM, but [Ca(2+)](i) required for scrambling is reported to be much higher (around 100μM). In this work, FITC-labelled lactadherin and FACS were used to measure externalised PS, with [Ca(2+)](i) altered using bromo-A23187 and EGTA/Ca(2+) mixtures. Two components of Ca(2+)-induced scrambling were apparent, of high (EC(50) 1.8±0.3μM) and low (306±123μM) affinity, in RBCs from normal individuals and the commonest SCD genotypes, HbSS and HbSC. The high affinity component was lost in the presence of unphysiologically high [Mg(2+)] but was unaffected by high K(+) (90mM) or vanadate (1mM). The high affinity component accounted for PS scrambling in ≥2/3rd RBCs. It is likely to be most significant in vivo and may be involved in the pathophysiology of SCD or other conditions involving eryptosis.
authors.affiliation: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
authors.forename: Erwin
authors.initials: E
authors.lastname: Weiss
authors.forename: Urszula M
authors.initials: UM
authors.lastname: Cytlak
authors.forename: David C
authors.initials: DC
authors.lastname: Rees
authors.forename: Anna
authors.initials: A
authors.lastname: Osei
authors.forename: John S
authors.initials: JS
authors.lastname: Gibson
mesh_terms: D000755:Anemia, Sickle Cell / Q000378:metabolism* / Q000473:pathology*; D002118:Calcium / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism*; D005089:Exocytosis / Q000187:drug effects*; D006801:Humans; D042541:Intracellular Space / Q000187:drug effects / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology*; D010718:Phosphatidylserines / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D014638:Vanadates / Q000494:pharmacology
chemical_list: D010718:Phosphatidylserines; D014638:Vanadates; D008274:Magnesium; D011188:Potassium; D010100:Oxygen; D002118:Calcium